Showing results (961-970 of 996) with videos related to
Sort By:
Pageof 100
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.Nature Immunology|December 30, 2025
Adenophages are an atypical macrophage population in exocrine glands sustained by ILC2-derived GM-CSFFrederike Westermann, Selma Tuzlak, Victor Kreiner, et al.Cancers|March 13, 2025
Epidemiology of Thyroid Cancer in Tuscany (Central Italy) 2013-2017: Not Just OverdiagnosisMarco Capezzone, Liborio Torregrossa, Anello Marcello Poma, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2016
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST StudyClaudia Torino, Luna Gargani, Rosa Sicari, et al.Journal for Immunotherapy of Cancer|June 15, 2023
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy studySophie Papa, Antonella Adami, Michael Metoudi, et al.Thyroid : Official Journal of the American Thyroid Association|September 20, 2021
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)Raffaella Forleo, Giorgio Grani, Marco Alfò, et al.Cancer|January 18, 2024
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131Karen L Smith, Fengmin Zhao, Ingrid A Mayer, et al.Frontiers in Oncology|April 4, 2022
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Andrea Patriarca, Mario Luppi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2017
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083George Somlo, Paul H Frankel, Banu K Arun, et al.Journal of Nephrology|January 10, 2020
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal studyClaudia Torino, Luna Gargani, Rosa Sicari, et al.Pageof 100